PDL BioPharma Inc (PDLI.OQ)

PDLI.OQ on NASDAQ Stock Exchange Global Select Market

21 Nov 2014
Price Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for PDLI.OQ


PDL BioPharma, Inc. (PDL) is a is a biotech company. PDL is engaged in the management of antibody humanization patents and royalty assets, which consist of its Queen et al. patents and license agreements with various biotechnology and pharmaceutical companies. The Company receives royalties based on sales of humanized antibody... (more)


Beta: 0.57
Market Cap (Mil.): $1,261.14
Shares Outstanding (Mil.): 160.65
Dividend: 0.15
Yield (%): 7.64


  PDLI.OQ Industry Sector
P/E (TTM): 4.13 269.72 39.20
EPS (TTM): 1.90 -- --
ROI: 69.95 -1.77 17.16
ROE: 144.33 -3.18 18.09
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
Provider: Stock Traders Daily
Provider: Reuters Investment Profile
Provider: S&P Capital IQ Quantitative Report
Provider: Validea

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks